Current aspects of the quality of head and neck cancer care - survey of the Scandinavian Society for Head and Neck Oncology.

In the Nordic countries, the importance of HNC treatment timelines is well acknowledged. There is a lack of consensus on the composition of MTB meeting, and how treatment-related morbidity should be monitored outside clinical trials.